We’re a few weeks into 2023, and while some new year’s resolutions may have already fallen to the wayside, there are plenty of food law issues that will take us through 2023 and beyond. Here are key issues the Hogan Lovells...more
The U.S. Food & Drug Administration (FDA) recently issued Warning Letters to five companies selling products containing delta-8 tetrahydrocannabinol (delta-8 THC) and cannabidiol (CBD). In addition to the various violations...more
On 19 February, 2021 the U.S. Food and Drug Administration (FDA) announced warning letters to ten companies for selling dietary supplements that claim to cure, treat, mitigate, or prevent depression and other mental health...more
2/25/2021
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Dietary Supplements ,
Enforcement Actions ,
FDA Warning Letters ,
Food and Drug Administration (FDA) ,
Health and Safety ,
Health Claims ,
Marijuana ,
Marketing ,
Medical Foods ,
Mental Health ,
Pharmaceutical Industry ,
Plant Based Products ,
Product Labels ,
Regulatory Oversight
While the hemp industry eagerly awaits FDA’s Cannabidiol (CBD) Enforcement Policy draft guidance, both the United States Department of Agriculture (USDA) and Drug Enforcement Agency (DEA) have active comment periods ongoing...more
9/25/2020
/ Agribusiness ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
DEA ,
Decriminalization of Marijuana ,
Dietary Supplements ,
Farm Bill ,
Hemp ,
Hemp Cultivation ,
Hemp Related Businesses ,
Interim Final Rules (IFR) ,
Medical Foods ,
Plant Based Products ,
Regulatory Agenda ,
Retail Market ,
Rulemaking Process ,
USDA
Tell me if you’ve heard this one before – the regulatory issues surrounding CBD will be completely resolved after a certain “legislative fix” is passed. Remember all of the articles in December 2018 declaring CBD legal after...more
8/10/2020
/ Agribusiness ,
Alternative Medicine ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Dietary Supplements ,
Farm Bill ,
Food and Drug Administration (FDA) ,
Marijuana ,
Medical Foods ,
Plant Based Products ,
Regulatory Oversight ,
Retail Market
The Council for Responsible Nutrition (CRN) submitted a citizen petition to the Food and Drug Administration (FDA) requesting that FDA:
FDA exercise its statutory authority to establish a regulation under which...more
6/26/2020
/ Agribusiness ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Citizen Petitions ,
Dietary Supplements ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Hemp ,
Marijuana ,
Medical Foods ,
Plant Based Products ,
Regulatory Oversight ,
Rulemaking Process
Increasing consumer interest in cannabis-derived ingredients has led to an explosion of the use of the non-intoxicating cannabinoid, cannabidiol (CBD) in a wide variety of products, including drugs, foods, dietary...more
5/7/2019
/ Cannabidiol (CBD) oil ,
Controlled Substances Act ,
Cosmetics ,
Dietary Supplements ,
Farm Bill ,
Food and Drug Administration (FDA) ,
Food Manufacturers ,
Hemp ,
Marijuana Related Businesses ,
Marketing ,
Nutritional Supplements ,
UK
Many food and beverage companies are assessing the use of hemp-derived ingredients in their products in light of the 2018 Farm Bill provisions excluding “hemp” from the definition of marijuana under the federal Controlled...more
This post summarizes several regulatory developments related to cannabis and cannabis derivatives, including cannabidiol (CBD). The Food and Drug Administration (FDA) recently announced it will hold a public meeting on May...more
4/4/2019
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Decriminalization of Marijuana ,
Dietary Supplements ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Hemp ,
marij ,
Marijuana ,
Marijuana-Infused Edibles ,
OEHHA ,
Product Labels ,
Proposition 65 ,
Public Meetings ,
Warning Letters
On December 20, 2018, President Donald Trump signed the Agricultural Improvement Act of 2018 (the 2018 Farm Bill) into law.
...more
12/24/2018
/ Agricultural Sector ,
Cannabidiol (CBD) oil ,
Controlled Substances Act ,
Decriminalization of Marijuana ,
Farm Bill ,
Food and Drug Administration (FDA) ,
Hemp ,
Life Sciences ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Regulatory Oversight ,
Trump Administration ,
USDA